PRDX5 and cancer: The intracellular reduction of cystine to cysteine requires GSH or potentially thioredoxin reductase (Txnrd) dependent systems [30–32], and the GSH and Txn/Txnrd systems were shown to be partially redundant in embryonic stem cells, cancer cells and also in mouse liver [23, 31, 33].